---
layout: "post"
title: "Biotech startup tries unique weapon in fight against chronic pain and opioid addiction: snail venom"
date: "2017-02-23 15:25"
read_more: "http://www.kinetabio.com/pr/prhtml/pr20170222.html"
post_image: /images/posts/snail.jpg
post_credit: Haylie K. Romero et al. — Kineta, Inc
---
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
